Citalopram in doses of 20-60 mg is effective in depression relapse prevention: a placebo-controlled 6 month study.

Citalopram in doses of 20-60 mg is effective in depression relapse prevention: a placebo-controlled 6 month study.

Item
http://www.wikidata.org/entity/Q41677316
Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressantsPrevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled TrialsCitalopram--a review of pharmacological and clinical effects.Pharmacotherapy to sustain the fully remitted state.Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression.Efficacy of Desvenlafaxine 50 mg/d Versus Placebo in the Long-Term Treatment of Major Depressive Disorder: A Randomized, Double-Blind Trial.A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder.Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials.
P2860

Citalopram in doses of 20-60 mg is effective in depression relapse prevention: a placebo-controlled 6 month study.

Item
http://www.wikidata.org/entity/Q41677316
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Citalopram in doses of 20-60 m ...... cebo-controlled 6 month study.
@en
type
label
Citalopram in doses of 20-60 m ...... cebo-controlled 6 month study.
@en
prefLabel
Citalopram in doses of 20-60 m ...... cebo-controlled 6 month study.
@en
P1433
P1476
P2093
P304
P31
P478
P577
P698
P921
P1433
P1476
Citalopram in doses of 20-60 m ...... acebo-controlled 6 month study
@en
P2093
P304
P31
P478
P577
P698
P921